Rapid communication · 29 Dec 2025
EditorialPublished 2016
Ovarian Cancer Therapeutic Opportunities
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Among women in the United States, ovarian cancer is the fifth leading cause of cancer deaths, accounting for approximately 5% of all cancer deaths, with an estimated 22,280 new cases this year [1]. There are 239,000 new diagnoses and 152,000 deaths from the disease in 2012 worldwide. The four most common subtypes of ovarian cancer are serous, endometrioid, clear cell, and mucinous carcinoma based on distinct clinical and biological behaviors. Over 60% of ovarian cancer cases are diagnosed at a late stage of distant metastases or invasion due to lack of effective screening for detection. Currently, the standard treatment approach for patient with ovarian cancer is surgical intervention followed by platinum-based drugs plus taxane chemotherapy [2,3]. The 5-year survival rate for ovarian cancer patients with stage III or IV disease is under 20%. No effective therapy is available for relapsed or metastatic disease that has failed first-line chemotherapy [4]. However, this landscape may change because of the remarkable progress in precision medicine and cancer immunotherapy.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 22 Nov 2024
Chemoresistance in Ovarian Cancer: Mechanisms and Therapeutic Strategies
Conference abstract · 29 Aug 2017
Methanolic extract of Pistacia lentiscus (MEPL) as novel therapeutic approach in high-grade serous ovarian cancer
Review article · 2015
Therapeutic Innovations in Ovarian Cancer Treatment: The New England Perspective
Opinion · 30 Dec 2024
Inflammatory Microenvironment and it’s Role in Cancer Metastasis: Mechanisms and Therapeutic Opportunities
More from this journal
The newest in Reproductive Immunology: Open Access.
Perspective · 28 Feb 2025
Immunomodulatory Therapies for Recurrent Miscarriage: Current Perspectives
Brief report · 28 Feb 2025
Autoimmune Disorders and Their Influence on Female Fertility
Short communication · 28 Feb 2025
Natural Killer Cells and Their Impact on Reproductive Outcomes
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalReproductive Immunology: Open Access
- SubjectImmunology & Microbiology
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “De-Kuan Chang”

